Aveo Pharmaceuticals Inc
NASDAQ:AVEO
Aveo Pharmaceuticals Inc
Change in Working Capital
Aveo Pharmaceuticals Inc
Change in Working Capital Peer Comparison
Competitive Change in Working Capital Analysis
Latest Figures & CAGR of Competitors
Company | Change in Working Capital | CAGR 3Y | CAGR 5Y | CAGR 10Y | |
---|---|---|---|---|---|
Aveo Pharmaceuticals Inc
NASDAQ:AVEO
|
Change in Working Capital
-$294k
|
CAGR 3-Years
62%
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
Abbvie Inc
NYSE:ABBV
|
Change in Working Capital
$3.9B
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
38%
|
|
Gilead Sciences Inc
NASDAQ:GILD
|
Change in Working Capital
-$2.2B
|
CAGR 3-Years
-33%
|
CAGR 5-Years
-3%
|
CAGR 10-Years
-5%
|
|
Amgen Inc
NASDAQ:AMGN
|
Change in Working Capital
-$422m
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
-7%
|
|
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
|
Change in Working Capital
-$275.3m
|
CAGR 3-Years
-158%
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
|
Change in Working Capital
$105.5m
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
See Also
What is Aveo Pharmaceuticals Inc's Change in Working Capital?
Change in Working Capital
-294k
USD
Based on the financial report for Sep 30, 2022, Aveo Pharmaceuticals Inc's Change in Working Capital amounts to -294k USD.
What is Aveo Pharmaceuticals Inc's Change in Working Capital growth rate?
Change in Working Capital CAGR 3Y
62%
Over the last year, the Change in Working Capital growth was 92%. The average annual Change in Working Capital growth rates for Aveo Pharmaceuticals Inc have been 62% over the past three years .